- Home
- TAIT vs NEUP Comparison
TAIT vs NEUP Comparison
Compare TAIT & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAIT
- NEUP
- Stock Information
- Founded
- TAIT 1989
- NEUP 1996
- Country
- TAIT United States
- NEUP United States
- Employees
- TAIT N/A
- NEUP N/A
- Industry
- TAIT Electronic Components
- NEUP
- Sector
- TAIT Technology
- NEUP
- Exchange
- TAIT Nasdaq
- NEUP Nasdaq
- Market Cap
- TAIT 13.1M
- NEUP 12.7M
- IPO Year
- TAIT 1995
- NEUP N/A
- Fundamental
- Price
- TAIT $2.08
- NEUP $8.10
- Analyst Decision
- TAIT
- NEUP Strong Buy
- Analyst Count
- TAIT 0
- NEUP 1
- Target Price
- TAIT N/A
- NEUP $21.00
- AVG Volume (30 Days)
- TAIT 5.7K
- NEUP 38.6K
- Earning Date
- TAIT 08-14-2025
- NEUP 08-26-2025
- Dividend Yield
- TAIT 9.66%
- NEUP N/A
- EPS Growth
- TAIT N/A
- NEUP N/A
- EPS
- TAIT 0.01
- NEUP 0.00
- Revenue
- TAIT $4,260,000.00
- NEUP $15,662,715.00
- Revenue This Year
- TAIT N/A
- NEUP N/A
- Revenue Next Year
- TAIT N/A
- NEUP N/A
- P/E Ratio
- TAIT $219.59
- NEUP $4,767.51
- Revenue Growth
- TAIT N/A
- NEUP N/A
- 52 Week Low
- TAIT $2.01
- NEUP $2.90
- 52 Week High
- TAIT $3.05
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- TAIT 35.46
- NEUP N/A
- Support Level
- TAIT $2.10
- NEUP N/A
- Resistance Level
- TAIT $2.18
- NEUP N/A
- Average True Range (ATR)
- TAIT 0.05
- NEUP 0.00
- MACD
- TAIT -0.00
- NEUP 0.00
- Stochastic Oscillator
- TAIT 14.29
- NEUP 0.00
About TAIT Taitron Components Incorporated
Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.